Target Price | CHF4,294.20 |
Price | CHF3,878.00 |
Potential | 10.73% |
Number of Estimates | 26 |
26 Analysts have issued a price target Givaudan 2026 . The average Givaudan target price is CHF4,294.20. This is 10.73% higher than the current stock price. The highest price target is CHF5,040.00 29.96% , the lowest is CHF3,535.00 8.84% . | |
A rating was issued by 30 analysts: 14 Analysts recommend Givaudan to buy, 12 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Givaudan stock has an average upside potential 2026 of 10.73% . Most analysts recommend the Givaudan stock at Purchase. |
25 Analysts have issued a sales forecast Givaudan 2025 . The average Givaudan sales estimate is CHF7.9b . This is 6.04% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.3b 12.06% , the lowest is CHF7.4b 0.65% .
This results in the following potential growth metrics:
2024 | CHF7.4b | 7.19% |
---|---|---|
2025 | CHF7.9b | 6.04% |
2026 | CHF8.2b | 4.47% |
2027 | CHF8.6b | 5.12% |
2028 | CHF9.2b | 6.44% |
2029 | CHF9.1b | 0.57% |
2030 | CHF9.1b | 0.34% |
2031 | CHF9.7b | 6.24% |
2032 | CHF9.9b | 2.84% |
24 Analysts have issued an Givaudan EBITDA forecast 2025. The average Givaudan EBITDA estimate is CHF1.9b . This is 23.55% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF2.0b 31.69% , the lowest is CHF1.6b 6.12% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF1.5b | 23.35% |
---|---|---|
2025 | CHF1.9b | 23.55% |
2026 | CHF2.0b | 4.90% |
2027 | CHF2.1b | 5.12% |
2028 | CHF2.2b | 4.15% |
2029 | CHF2.3b | 4.49% |
2024 | 20.74% | 15.08% |
---|---|---|
2025 | 24.16% | 16.51% |
2026 | 24.26% | 0.41% |
2027 | 24.26% | 0.00% |
2028 | 23.74% | 2.14% |
2029 | 24.95% | 5.10% |
26 Givaudan Analysts have issued a net profit forecast 2025. The average Givaudan net profit estimate is CHF1.2b . This is 12.34% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.3b 23.10% , the lowest is CHF1.1b 0.75% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.1b | 22.06% |
---|---|---|
2025 | CHF1.2b | 12.34% |
2026 | CHF1.3b | 5.93% |
2027 | CHF1.4b | 7.03% |
2028 | CHF1.4b | 3.69% |
2029 | CHF1.5b | 1.26% |
2024 | 14.71% | 13.88% |
---|---|---|
2025 | 15.58% | 5.94% |
2026 | 15.80% | 1.41% |
2027 | 16.08% | 1.77% |
2028 | 15.67% | 2.55% |
2029 | 15.95% | 1.79% |
26 Analysts have issued a Givaudan forecast for earnings per share. The average Givaudan EPS is CHF132.66 . This is 12.86% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF145.37 23.68% , the lowest is CHF118.98 1.23% .
This results in the following potential growth metrics and future valuations:
2024 | CHF117.63 | 21.93% |
---|---|---|
2025 | CHF132.66 | 12.78% |
2026 | CHF140.52 | 5.92% |
2027 | CHF150.40 | 7.03% |
2028 | CHF155.94 | 3.68% |
2029 | CHF157.90 | 1.26% |
Current | 32.68 | 26.03% |
---|---|---|
2025 | 28.95 | 11.41% |
2026 | 27.33 | 5.60% |
2027 | 25.54 | 6.55% |
2028 | 24.63 | 3.56% |
2029 | 24.33 | 1.22% |
Based on analysts' sales estimates for 2025, the Givaudan stock is valued at an EV/Sales of 5.09 and an P/S ratio of 4.59 .
This results in the following potential growth metrics and future valuations:
Current | 5.40 | 14.42% |
---|---|---|
2025 | 5.09 | 5.66% |
2026 | 4.88 | 4.28% |
2027 | 4.64 | 4.87% |
2028 | 4.36 | 6.05% |
2029 | 4.38 | 0.57% |
2030 | 4.40 | 0.34% |
2031 | 4.14 | 5.87% |
2032 | 4.03 | 2.76% |
Current | 4.86 | 14.51% |
---|---|---|
2025 | 4.59 | 5.70% |
2026 | 4.39 | 4.28% |
2027 | 4.18 | 4.87% |
2028 | 3.92 | 6.05% |
2029 | 3.95 | 0.57% |
2030 | 3.96 | 0.34% |
2031 | 3.73 | 5.87% |
2032 | 3.62 | 2.76% |
Analyst | Rating | Action | Date |
---|---|---|---|
RESEARCH PARTNERS AG |
Buy
➜
Buy
|
Unchanged | Apr 02 2025 |
BERENBERG |
Hold
➜
Buy
|
Upgrade | Mar 31 2025 |
ESN/CIC MARKET SOLUTIONS |
Neutral
➜
Neutral
|
Unchanged | Mar 30 2025 |
BAADER HELVEA EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Mar 25 2025 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Mar 20 2025 |
JEFFERIES |
Underperform
➜
Underperform
|
Unchanged | Mar 12 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RESEARCH PARTNERS AG:
Buy
➜
Buy
|
Apr 02 2025 |
Upgrade
BERENBERG:
Hold
➜
Buy
|
Mar 31 2025 |
Unchanged
ESN/CIC MARKET SOLUTIONS:
Neutral
➜
Neutral
|
Mar 30 2025 |
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
➜
Buy
|
Mar 25 2025 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Mar 21 2025 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Mar 20 2025 |
Unchanged
JEFFERIES:
Underperform
➜
Underperform
|
Mar 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.